New biobank aims to unlock genetic secrets of heart disease
NCT ID NCT05067231
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is building a biobank of DNA samples and health information from 500 adults. Researchers will use this resource to explore how genetic variations relate to heart disease, high blood pressure, diabetes, and obesity. Participants provide samples and data, but no experimental treatment is given.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this biobank could help researchers discover genetic factors that influence heart disease and related conditions.
- What could go wrong
- This is an observational biobank, not a treatment trial. It will not directly benefit participants and may not yield immediate findings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can better healthcare access save hearts after prison?
- Can a Two-Drug combo tip the scales against obesity?
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Can Weight-Loss surgery change how medications work?
- Can lifestyle choices after a stroke extend life and prevent a second one?